With weight loss drugs now common, the Times looks at how doctors are struggling to spot eating disorders in patients.
Recap by typeshit. Full story at The New York Times.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A GP shares her own weight loss story and the long stretch of difficulty that came before the results people now see.
A first month is expected to cost about 129,800 won, roughly half of Mounjaro in Korea, while smuggling of cheaper Mounjaro from Japan has jumped 4.2 times.
Loading…